. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "454"^^ . "Randomized Phase II 2 x 2 Factorial Trial of the Addition of Carboplatin +/- Bevacizumab to Neoadjuvant Weekly Paclitaxel Followed by Dose-Dense AC in Hormone Receptor-Poor/HER2-Negative Resectable Breast Cancer"@en . . . "klinisch onderzoek"@nl . . "\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk . "ensayu cl\u00EDnicu"@ast . . . . "NCT00861705" . . . . . . "ensayo cl\u00EDnico"@es . "Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery"@en . . . . . "clinical trial"@en . . "18"^^ . . . "Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery"@en . . "Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery"@en . . . . . . . . "2009-05-15T00:00:00Z"^^ . . . . . "2014-08-01T00:00:00Z"^^ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .